The hyaluronic acid market size is expected to see strong growth in the next few years. It will grow to $11.93 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing demand for anti-aging solutions, rising adoption of regenerative medicine applications, expansion of pharmaceutical-grade hyaluronic acid usage, growing focus on sustainable sourcing, increasing investments in advanced formulation technologies. Major trends in the forecast period include increasing demand for injectable aesthetic treatments, rising use of hyaluronic acid in osteoarthritis care, growing adoption of microbial fermentation production, expansion of multi-application formulations, enhanced focus on high-purity grades.
The rising number of aesthetic procedures is anticipated to fuel the growth of the hyaluronic acid market in the coming years. Aesthetic procedures are treatments and interventions aimed at enhancing appearance, refining features, and rejuvenating the skin or body to achieve a more youthful and balanced look. The demand for these procedures is increasing as technological advancements have made them safer, less invasive, and more effective, encouraging more individuals to undergo them. Hyaluronic acid is a vital component in aesthetic procedures, assisting in restoring facial volume, minimizing wrinkles, and improving skin hydration for a smoother and more youthful appearance. For instance, in June 2025, according to the American Society of Plastic Surgeons, a US-based Plastic Surgery Foundation, over 800,000 patients underwent aesthetic procedures in 2024, with tummy tucks ranking second in popularity and showing a 1% increase from 2023, while facelifts and forehead lifts each saw a 1% rise as well. Therefore, the increase in aesthetic procedures is contributing to the growth of the hyaluronic acid market.
Major companies operating in the hyaluronic acid market are focusing on developing innovative products, such as novel cationic hyaluronic acid, to enhance skin adhesion, improve hydration performance, and expand applications in rinse-off formulations. Novel cationic hyaluronic acid is a positively charged, chemically modified form of hyaluronic acid created to increase adhesion, cellular interaction, and stability for advanced medical and cosmetic applications. For instance, in March 2023, Givaudan S.A., a Switzerland-based chemicals company, launched PrimalHyal Hydra, a novel cationic hyaluronic acid produced using white biotechnology that sets a new standard for skin hydration. This advanced active ingredient provides immediate hydration after a single application and maintains moisturization for up to four days, surpassing standard hyaluronic acid performance by at least two times. It works effectively in both rinse-off and leave-on cosmetic formulations and supports the skin barrier by promoting lipid and protein production. The ingredient is clinically tested and designed for broad use across skincare products, including lotions, shower gels, and masks, delivering long-lasting hydration and skin barrier reinforcement with enhanced skin adhesion properties.
In July 2025, Waldencast plc, a UK-based beauty and wellness company, acquired Novaestiq Corp. for an undisclosed sum. Through this acquisition, Waldencast aims to strategically expand Obagi Medical's product portfolio beyond medical-grade skincare into the rapidly growing U.S. dermal filler market, effectively doubling its addressable market and establishing Obagi Medical as a leader in integrated skincare and aesthetic solutions to drive significant growth and innovation in the aesthetics sector. Novaestiq Corp. is a US-based company that develops and markets aesthetic and dermatological products, with a focus on hyaluronic acid dermal fillers.
Major companies operating in the hyaluronic acid market are AbbVie Inc., L'Oréal S.A., LG Chem Ltd., Shiseido Company Limited, Givaudan SA, Zimmer Biomet Holdings Inc., Grifols S.A., Smith & Nephew plc, Kikkoman Biochemifa Company Ltd., Galderma S.A., Kewpie Corporation, Merz Pharma GmbH & Co. KGaA, Fidia Farmaceutici S.p.A., Anika Therapeutics Inc., Lifecore Biomedical Inc., Croma-Pharma GmbH, Contipro a.s., Seikagaku Corporation, HTL Biotechnology SAS, Altergon Italia S.r.l., Bloomage Biotechnology Corporation Limited.
North America was the largest region in the hyaluronic acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyaluronic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hyaluronic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hyaluronic acid market by increasing costs of imported fermentation equipment, purification systems, medical-grade packaging materials, and pharmaceutical processing machinery. Cosmetic and pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported production inputs, while Asia-Pacific faces cost pressure on export-oriented manufacturing. These tariffs are raising production costs and influencing pricing across aesthetics and medical segments. However, they are also driving localized production, investment in domestic fermentation facilities, and supply chain diversification for hyaluronic acid manufacturing.
The hyaluronic acid market research report is one of a series of new reports that provides hyaluronic acid market statistics, including hyaluronic acid industry global market size, regional shares, competitors with a hyaluronic acid market share, detailed hyaluronic acid market segments, market trends and opportunities, and any further data you may need to thrive in the hyaluronic acid industry. This hyaluronic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hyaluronic acid is a naturally occurring substance in the human body, mainly found in the skin, connective tissues, and eyes. It functions as a lubricant and cushion for joints and tissues, while also playing a key role in retaining moisture. Because of its high water-holding capacity, it helps preserve the skin’s hydration, fullness, and elasticity. It is widely used in skincare products for moisturizing and anti-aging benefits, as well as in medical applications such as joint injections for osteoarthritis, wound repair, and eye surgeries.
The main types of products containing hyaluronic acid are single-injection doses and multiple-injection doses. A multiple-injection dose involves delivering a medication through several injections over time to sustain effective therapeutic levels in the body. It includes various grades, such as pharmaceutical-grade hyaluronic acid and cosmetic-grade hyaluronic acid, and is derived from different sources, including microbial fermentation, animal-based, and plant-based origins. It is utilized in active pharmaceutical ingredients, aesthetics, osteoarthritis, cosmetics, ophthalmology, and dietary supplements and caters to a broad range of end users, including dermatology clinics, cosmetic surgery centers, medical spas, beauty centers, and others.
The hyaluronic acid market consists of sales of hyaluronic acid serums, moisturizers, facial masks, dermal fillers, viscosupplements, burn and ulcer treatments, and eye drops. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Hyaluronic Acid Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hyaluronic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hyaluronic acid? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hyaluronic acid market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Multiple Injection Dose; Single Injection Dose2) By Grade: Pharmaceutical Grade Hyaluronic Acid; Cosmetic Grade Hyaluronic Acid
3) By Source: Microbial Fermentation; Animal Based; Plant Based
4) By Application: Pharmaceutical Active Pharmaceutical Ingredient; Aesthetics; Osteoarthritis; Cosmetics; Ophthalmology; Dietary Supplements
5) By End User: Dermatology Clinics; Cosmetic Surgery Centers; Medical Spas And Beauty Centers; Other End Users
Subsegments:
1) By Multiple Injection Dose: Pre-Filled Syringes; Vials With Reconstitution Kits; Combination Therapy Formats; Extended-Release Formulations2) By Single Injection Dose: Pre-Filled Single-Use Syringes; Ampoules; Cartridges; Ready-To-Inject Pens
Companies Mentioned: AbbVie Inc.; L'Oréal S.A.; LG Chem Ltd.; Shiseido Company Limited; Givaudan SA; Zimmer Biomet Holdings Inc.; Grifols S.A.; Smith & Nephew plc; Kikkoman Biochemifa Company Ltd.; Galderma S.A.; Kewpie Corporation; Merz Pharma GmbH & Co. KGaA; Fidia Farmaceutici S.p.A.; Anika Therapeutics Inc.; Lifecore Biomedical Inc.; Croma-Pharma GmbH; Contipro a.s.; Seikagaku Corporation; HTL Biotechnology SAS; Altergon Italia S.r.l.; Bloomage Biotechnology Corporation Limited.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hyaluronic Acid market report include:- AbbVie Inc.
- L'Oréal S.A.
- LG Chem Ltd.
- Shiseido Company Limited
- Givaudan SA
- Zimmer Biomet Holdings Inc.
- Grifols S.A.
- Smith & Nephew plc
- Kikkoman Biochemifa Company Ltd.
- Galderma S.A.
- Kewpie Corporation
- Merz Pharma GmbH & Co. KGaA
- Fidia Farmaceutici S.p.A.
- Anika Therapeutics Inc.
- Lifecore Biomedical Inc.
- Croma-Pharma GmbH
- Contipro a.s.
- Seikagaku Corporation
- HTL Biotechnology SAS
- Altergon Italia S.r.l.
- Bloomage Biotechnology Corporation Limited.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.54 Billion |
| Forecasted Market Value ( USD | $ 11.93 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |


